)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
InMed Pharmaceuticals (INM) investor relations material
InMed Pharmaceuticals Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary23 Sep, 2025
Executive summary
Advanced INM-901 program targeting multiple biological pathways in Alzheimer's disease, with significant neuroinflammation reduction and cognitive improvements in preclinical models.
Progressed INM-089 for dry age-related macular degeneration, selecting an intravitreal formulation and demonstrating neuroprotection in preclinical studies.
BayMedica subsidiary achieved $4.9M in sales, up 8% year-over-year, maintaining a strong position in rare cannabinoids.
Cash position of $11.1M expected to fund operations into Q4 2026.
Financial highlights
Net loss of $8.2M for the year ended June 30, 2025, compared to $7.7M in the prior year.
Research and development expenses decreased to $2.9M from $3.2M year-over-year.
General and administrative expenses increased to $6.6M from $5.8M year-over-year.
BayMedica sales reached $4.9M, an 8% increase over the previous year.
Cash, cash equivalents, and short-term investments totaled $11.1M as of June 30, 2025.
Outlook and guidance
Plans to advance INM-901 through IND-enabling studies, CMC activities, and pre-IND meeting preparation in fiscal 2026.
Expects research and development expenses to increase significantly as pharmaceutical pipeline advances.
Cash reserves projected to support operations and development milestones into Q4 2026.
INM-901's AD strategy vs. market trends?
R&D increase: What are key funding assumptions?
INM-089: Next milestones and timeline?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next InMed Pharmaceuticals earnings date
Q1 202613 Nov, 2025
Next InMed Pharmaceuticals earnings date
Q1 202613 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
)
Edge19 Sep 2025
American Express: An Empire of Plastic
How history, brand, and structure have steadily built American Express' moat, and why Warren Buffett still calls it a one-of-a-kind business.
Frequently asked questions
InMed Pharmaceuticals Inc is a Canadian biotechnology company specializing in the research and development of rare cannabinoids. The company focuses on creating pharmaceutical and consumer health products derived from cannabinoid compounds using biosynthesis and chemical synthesis technologies. Its operations span proprietary drug development and manufacturing services. InMed Pharmaceuticals Inc is headquartered in Vancouver, Canada, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage